Platform Trial Designs for Biomarker-Driven Oncology Studies
Platform Trial Designs for Biomarker-Driven Oncology Studies Platform Trial Designs for Biomarker-Driven Oncology Studies Introduction to Platform Trials Platform trials represent a revolutionary approach to oncology drug development, particularly in biomarker-driven studies. Unlike traditional trials that focus on a single intervention, platform trials evaluate multiple treatments simultaneously under a single master protocol. This approach is…
Read More “Platform Trial Designs for Biomarker-Driven Oncology Studies” »